Latest Insider Transactions at Ocuphire Pharma, Inc. (OCUP)
This section provides a real-time view of insider transactions for Ocuphire Pharma, Inc. (OCUP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ocuphire Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ocuphire Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 01
2024
|
George Magrath Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,050
-8.62%
|
$37,050
$1.18 P/Share
|
Oct 22
2024
|
Jean Bennett |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
Jun 11
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+18.57%
|
-
|
Jun 11
2024
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+14.68%
|
-
|
Jun 11
2024
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+22.71%
|
-
|
Jun 11
2024
|
Cam Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+34.81%
|
-
|
Jun 11
2024
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+23.76%
|
-
|
Jun 11
2024
|
Sean Ainsworth |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+31.77%
|
-
|
May 22
2024
|
Ashwath Jayagopal Chief Scientific & Dev. Ofc. |
BUY
Open market or private purchase
|
Direct |
3,500
+4.27%
|
$3,500
$1.76 P/Share
|
May 17
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.15%
|
$5,000
$1.75 P/Share
|
Apr 11
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+18.68%
|
-
|
Mar 21
2024
|
Joseph K Schachle Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$4,000
$2.05 P/Share
|
Mar 21
2024
|
Nirav S. Jhaveri Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.25%
|
$20,000
$2.1 P/Share
|
Mar 18
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+5.56%
|
$25,000
$1.96 P/Share
|
Feb 12
2024
|
Ashwath Jayagopal Chief Scientific & Dev. Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
Feb 12
2024
|
Nirav S. Jhaveri Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
Jan 18
2024
|
Rabourn Amy Zaremba SVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+32.61%
|
-
|
Jan 18
2024
|
Bernhard Hoffmann SVP of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+10.95%
|
-
|
Jan 10
2024
|
Bernhard Hoffmann SVP of Corp. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,031
-2.75%
|
$12,093
$3.27 P/Share
|
Jan 10
2024
|
Ronil A. Patel Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,282
-1.39%
|
$3,846
$3.27 P/Share
|
Jan 10
2024
|
Rabourn Amy Zaremba SVP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-8.47%
|
$11,850
$3.27 P/Share
|
Jan 01
2024
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
22,090
+19.55%
|
-
|
Jan 01
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
14,964
+12.24%
|
-
|
Jan 01
2024
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+11.12%
|
-
|
Jan 01
2024
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
19,418
+16.41%
|
-
|
Dec 01
2023
|
Ronil A. Patel Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,692
+35.07%
|
-
|
Nov 01
2023
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+27.48%
|
-
|
Nov 01
2023
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+16.81%
|
-
|
Nov 01
2023
|
George Magrath Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+50.0%
|
-
|
Jun 06
2023
|
Cam Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
10,976
+23.41%
|
-
|
Jun 06
2023
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
10,976
+12.14%
|
-
|
Jun 06
2023
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
10,976
+16.06%
|
-
|
Jun 06
2023
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
10,976
+13.76%
|
-
|
Jun 06
2023
|
Sean Ainsworth |
BUY
Grant, award, or other acquisition
|
Direct |
10,976
+18.86%
|
-
|
Apr 24
2023
|
Ronil A. Patel Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+32.1%
|
-
|
Apr 19
2023
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
468
+1.0%
|
-
|
Apr 19
2023
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.56%
|
-
|
Apr 19
2023
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
1,053
+1.51%
|
-
|
Apr 19
2023
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
2,819
+4.65%
|
-
|
Jan 11
2023
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
20,822
+19.09%
|
-
|
Jan 11
2023
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
13,013
+22.09%
|
-
|
Jan 11
2023
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
18,544
+25.21%
|
-
|
Jan 11
2023
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
16,267
+19.43%
|
-
|
Jan 10
2023
|
Mina Sooch President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
134,456
+23.8%
|
-
|
Jan 10
2023
|
Rabourn Amy Zaremba SVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
46,608
+50.0%
|
-
|
Jan 10
2023
|
Bernhard Hoffmann SVP of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
46,608
+24.11%
|
-
|
Jan 04
2023
|
Cam Gallagher |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,574
+5.94%
|
-
|
Oct 19
2022
|
Sean Ainsworth |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,574
+3.68%
|
-
|
Oct 11
2022
|
James S J Manuso |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
787
+2.11%
|
-
|
Oct 03
2022
|
Richard J Rodgers |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,148
+4.46%
|
-
|